NANOS Gene Knockout for Livestock Germ Cell Ablation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing recipient animals for spermatogonial stem cell transplantation in livestock are limited by the need for chemotoxic drugs, which can be toxic and ineffective in large animals, and local testicular irradiation, which damages supporting cells and requires precise dosing.
Innovation Solution
Genetically editing animals to modulate NANOS gene activity, creating males without functional germ cells but with intact somatic support cells, using techniques like CRISPR/Cas, TALENs, or ZFNs to inactivate the NANOS gene, allowing for successful spermatogonial stem cell transplantation and fertility in females.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chemotoxic drugs are used to eliminate endogenous germ cells, then donor SSC colonization is improved, but somatic support cell function is damaged and toxicity occurs in large animals
Solution Approach 1:
The patent extracts and eliminates the harmful chemotoxic drugs from the recipient preparation process by using genetic modification (NANOS gene knockout) to selectively remove only germ cells while preserving somatic support cells. This extraction principle resolves the contradiction by removing the toxic agent while achieving the desired germ cell elimination.
Solution Approach 2:
The patent introduces NANOS gene knockout as an intermediary mechanism that selectively targets germ cells through a different biological pathway. Instead of using chemotoxic drugs that affect all cells, the genetic modification acts as a specific intermediary that eliminates germ cells while leaving somatic cells intact, thereby resolving the toxicity problem.
2Reliability
If local testicular irradiation is used to eliminate endogenous germ cells, then donor SSC colonization is improved, but supporting cells are damaged and precise dosing is required
Solution Approach 1:
The patent removes the need for precise irradiation dosing by extracting the irradiation step entirely and replacing it with genetic modification. The NANOS gene knockout approach eliminates germ cells through a biological mechanism that does not require precise physical dosing, thereby resolving the complexity issue.
Solution Approach 2:
The patent replaces the mechanical/physical system of irradiation with a biological system based on genetic modification. Instead of using physical energy (radiation) that requires precise dosing control, the patent uses biological mechanisms (gene knockout) that naturally achieve selective germ cell elimination without complex dosing requirements.
3Reliability
If chemotoxic drugs are used to eliminate persisting spermatogonia, then recipient preparation is improved, but unintended toxicity to bone marrow stem cells and other tissue-specific stem cells occurs
Solution Approach 1:
The patent introduces NANOS gene knockout as a specific intermediary that targets only germ cell lineage through a unique biological marker. This genetic intermediary provides selective elimination of germ cells while spares other stem cells, resolving the contradiction between effective recipient preparation and protection of other stem cell populations.
Solution Approach 2:
The patent applies local quality by making the recipient animals specifically deficient in NANOS gene function only in the germ cell lineage. This localized genetic modification ensures that only the intended target (germ cells) is affected while other cell types and stem cell populations remain unaffected, thereby resolving the toxicity issue.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the creation of recipient males lacking germ cells but retaining functional somatic cells, facilitating efficient spermatogonial stem cell transplantation and maintaining female fertility, thereby expanding the genetic merit and availability of sperm from desirable sires in livestock breeding.
Implementation Method 1
using techniques like CRISPR/Cas, TALENs, or ZFNs to inactivate the NANOS gene
Implementation Method 2
NANOS is an evolutionarily conserved family of RNA-binding proteins that are expressed specifically within the germ cells... Ablation of NANOS and its orthologs results in the loss of germ cells
Data Source
AI summary
The present invention provides livestock animals and methods to create recipient animals for spermatogonial stem cell transplantation through modulation of the NANOS gene. In one embodiment genome editing issued to create animals with insertions or deletions (indels) that inactivate or otherwise modulate NANOS gene activity so that resulting males lack functional germ cells yet retain functional somatic cells, and females are fertile. These males can then be transplanted with donor spermatogonial stem cells and used for breeding.